Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
912.60
1.55 (0.17%)
< Home < Back

Alivus Life Sciences informs about disclosure

Date: 20-10-2025
Pursuant to regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, Alivus Life Sciences has informed that the details of Notice/Order received by the Company from Office of The Gujarat Pollution Control Board (‘GPCB’) is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.